Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Rosalía Laporta-Hernández"'
Autor:
Javier Segovia-Cubero, Lorena Ruiz-Bautista, Luis Maiz-Carro, Rosa M. Girón-Moreno, M. Concepción Prados-Sánchez, M. Teresa Martínez-Martínez, Montserrat González-Estecha, Susana Mingo-Santos, Manuel Gómez-Bueno, Clara Salas-Antón, Miguel A. Cavero-Gibanel, Miguel Pastrana-Ledesma, Pablo García-Pavía, Rosalía Laporta-Hernández, David Sánchez-Ortiz, Luis Alonso-Pulpón
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
IntroductionWe conducted a study to determine the prevalence of structural heart disease in patients with CF, the characteristics of a cardiomyopathy not previously described in this population, and its possible relationship with nutritional deficien
Externí odkaz:
https://doaj.org/article/48992d6432c54ed2998117dc08b6846f
Autor:
Rosa Gutiérrez-Larraya-Sánchez-Andrade, Marta Erro-Iribarren, Silvia Aguado-Ibáñez, Myriam Aguilar-Pérez, Rosalía Laporta-Hernández, Cristina López-García-Gallo, Carlos Almonacid-Sánchez, Piedad Ussetti-Gil
Publikováno v:
Revista de Patología Respiratoria, Vol 27, Iss 1 (2024)
Antecedentes: Los trasplantados pulmonares son un grupo con mayor riesgo de desarrollar enfermedad por coronavirus 2019 (COVID-19) grave. El sotrovimab demostró reducir el riesgo de progresión de enfermedad y ha sido utilizado en pacientes con tras
Externí odkaz:
https://doaj.org/article/04efd9c9dbc04e5c96f8505be382a048
Autor:
Felipe Villar-Álvarez, Miguel Ángel Martínez-García, David Jiménez, Fernando Fariñas-Guerrero, Raúl Ortiz de Lejarazu-Leonardo, José Luis López-Campos, Marina Blanco-Aparicio, Íñigo Royo-Crespo, Alberto García-Ortega, Antoni Trilla-García, Juan Carlos Trujillo-Reyes, María Fernández-Prada, David Díaz-Pérez, Rosalía Laporta-Hernández, Claudia Valenzuela, Rosario Menéndez, David de la Rosa-Carrillo
Publikováno v:
Open Respiratory Archives, Vol 3, Iss 2, Pp 100097- (2021)
Resumen: La Sociedad Española de Neumología y Cirugía Torácica (SEPAR) ha elaborado este documento de recomendaciones sobre la vacuna para la COVID-19 en las enfermedades respiratorias, con el objetivo de ayudar al personal sanitario en la toma d
Externí odkaz:
https://doaj.org/article/c272f6156eb04e86b2151c4184e3a085
Donor lungs cold preservation at 10 °C offers a potential logistic advantage in lung transplantation
Autor:
Mariana Gil Barturen, Rosalía Laporta Hernández, Antonio Romero Berrocal, Marina Pérez Redondo, Alejandra Romero Román, Silvana Crowley Carrasco, Lucas Hoyos Mejía, Pablo Cordero Iglesias, Jose Manuel Naranjo Gómez, Mar Córdoba Peláez, David Gómez de Antonio, Jose Luis Campo-Cañaveral de la Cruz
Publikováno v:
Cirugía Española (English Edition). 101:283-286
Donor lung preservation at 10 °C appears to be an innovative and promising method that may improve transplant logistics by extending the cold ischemia time with excellent outcomes. We report the case of two lung transplants from two different donors
Autor:
Gil, Silvia Aguado Ibáñez, Rosalía Laporta Hernández, Myriam Aguilar Pérez, Christian García Fadul, Cristina López García Gallo, Gema Díaz Nuevo, Sonia Salinas Castillo, Raquel Castejón Diaz, Clara Salas Anton, Ana Royuela Vicente, Francisco Antonio Bernabeu Andreu, María Piedad Ussetti
Publikováno v:
Transplantology; Volume 4; Issue 3; Pages: 102-110
The usefulness of bronchoalveolar lavage fluid (BALF) to support the diagnosis of acute cellular (ACR) rejection in lung transplant (LTX) recipients remains controversial. ACR has been associated with blood eosinophil counts (EOS) in other solid orga
Autor:
Víctor Manuel Mora Cuesta, David Iturbe Fernández, Silvia Aguado Ibáñez, Gabriel Anguera de Francisco, Juan Margallo Iribarnegaray, Javier Carrillo Hernández‐Rubio, Juan Pablo Reig Mezquida, Virginia Pérez Luz, Rosalía Laporta Hernández, Alicia de Pablo Gafas, Amparo Solé Jover, José Manuel Cifrián Martínez
Publikováno v:
Respirology. 27:1054-1063
Antifibrotic drugs are the standard treatments for patients with idiopathic pulmonary fibrosis (IPF). This study aims to assess the safety of antifibrotic treatment in IPF patients undergoing lung transplantation.Patients with a diagnosis of IPF who
Autor:
Raquel, López-Vilella, Manuel, Gómez Bueno, Francisco, González Vílchez, Amparo, Solé Jover, Rosalía, Laporta Hernández, Rosario, Vicente Guillén, Ana Isabel, González Román, Ignacio, Sánchez-Lázaro, Francisco, Hernández Pérez, Gabriel, Sales Badía, María Del Mar, Córdoba Peláez, Salvador, Torregrosa Puerta, Alberto, Forteza Gil, Víctor, Donoso Trenado, Luis, Martínez Dolz, Javier, Segovia Cubero, Luis, Almenar Bonet
Publikováno v:
Transplantation Proceedings. 54:2500-2502
The outcomes of heart-lung transplant (HLT) are worse than those of heart transplant (HT) and lung transplant alone; this and the availability of mechanical assistance have meant that the indications for HLT have been changing. This study aims to ana
Autor:
Gemma María Mora Ortega, Rosalía Laporta Hernández, Mª Asuncion Nieto Barbero, Fredeswinda Romero Bueno, Belén López Muñiz Ballesteros, Lydia Abasolo Alcazar, Olga Sánchez Pernaute, Laura Cebrián Martínez, Cristina Vadillo Font, Mª Jesús Rodríguez-Nieto, Tatiana Cobo Ibánez, Mª Teresa Río Martínez
Publikováno v:
ILD / DPLD of known origin.
Autor:
Sandra Tejado Bravo, Myriam Aguilar Perez, Maria Teresa Lazaro Carrasco de la Fuente, Marta Erro Iribarren, Alfonso Ortega López, Rosalía Laporta Hernández, Piedad Ussetti Gil
Publikováno v:
Transplantation.
Purpose: There are few studies that analyze the early and late outcomes of lung transplant (LTx) recipients who required admission in an ICU. We aim to evaluate the characteristics and outcomes of LTX recipients who were admitted to the ICU. Methods:
Autor:
Silvia Aguado Ibañez, María Piedad Ussetti Gil, Rosalía Laporta Hernández, Javier Carrillo Hernández-Rubio
Publikováno v:
Transplantation.
Introduction: It has been postulated that antifibrotics could increase the incidence of post-transplantation complications in patients with idiopathic pulmonary fibrosis (IPF). The aim of our study is to analyze the incidence of complications and sur